VOICED : Brasil recibe Cumbre Mundial de Hepatitis en medio de protestas

Activists protested in Sao Paulo against Gilead's high costs for hepatitis C treatment. The protest coincided with the global hepatitis summit aimed at developing a strategy against the disease, which causes 1.3 million deaths annually. The cost of the treatment is significantly higher than production costs, raising concerns about profit margins. The WHO reported that a record number of people accessed hepatitis C treatment recently, but many in poorer countries still lack access due to high costs. Generic drugs offer some hope, but accessibility remains a major issue.

What new insight or understanding did you gain from this video?